All Stories

  1. Classical celiac disease is more frequent with a double dose of HLA-DQB1*02: A systematic review with meta-analysis
  2. Az endoszkópos regiszterek szerepe a minőségi betegellátásban. Az új magyar Endoszkópos Retrográd Cholangiopancreatographia (ERCP) Regiszter első eredményei
  3. Elevated Expression of AXL May Contribute to the Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease Patients
  4. Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort
  5. High versus low energy administration in the early phase of acute pancreatitis (GOULASH trial): protocol of a multicentre randomised double-blind clinical trial
  6. Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies
  7. Transpancreatic sphincterotomy has a higher cannulation success rate than needle-knife precut papillotomy – a meta-analysis
  8. Is Heller myotomy better than balloon dilation? A meta-analysis
  9. Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort
  10. Chronic pancreatitis: Multicentre prospective data collection and analysis by the Hungarian Pancreatic Study Group
  11. Meta-Analysis of the Long Term Success Rate of Different Interventions in Benign Biliary Strictures
  12. Genetic Analysis of Human Chymotrypsin-Like Elastases 3A and 3B (CELA3A and CELA3B) to Assess the Role of Complex Formation between Proelastases and Procarboxypeptidases in Chronic Pancreatitis
  13. Prediction of Short- and Medium-term Efficacy of Biosimilar Infliximab Therapy. Do Trough Levels and Antidrug Antibody Levels or Clinical And Biochemical Markers Play the More Important Role?
  14. Prospective, Multicentre, Nationwide Clinical Data from 600 Cases of Acute Pancreatitis
  15. Pancreatic cancer: multicenter prospective data collection and analysis by the Hungarian pancreatic study group
  16. Az adalimumab hatékonysága és biztonságossága hagyományos kezelésre refrakter colitis ulcerosában
  17. Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort
  18. Efficacy and Safety of Adalimumab in Ulcerative Colitis Refractory to Conventional Therapy in Routine Clinical Practice
  19. Genetic analysis of the bicarbonate secreting anion exchanger SLC26A6 in chronic pancreatitis
  20. Nem invazív fibrosisdiagnosztika hepatitis C-vírus-infekcióban: szerepe a kezelés indikációjában, követésében és a prognózis megítélésében
  21. Preventive pancreatic stents in the management of acute biliary pancreatitis (PREPAST trial): Pre-study protocol for a multicenter, prospective, randomized, interventional, controlled trial
  22. Faecal microbiota transplantation inClostridium difficileinfections
  23. Experience with fecal microbiota transplantation in the treatment of Clostridium difficile infection
  24. Upregulation of the Transient Receptor Potential Ankyrin 1 Ion Channel in the Inflamed Human and Mouse Colon and Its Protective Roles
  25. Retrospective analysis of patients with acute pancreatitis in hungary based on the data from the Hungarian National Pancreas Registry
  26. Retrospective analysis of patients with chronic pancreatitis in Hungary based on the data from the Hungarian National Pancreas Registry
  27. A common SLC26A6 haplotype is not associated with chronic pancreatitis
  28. Transient elastography as a predictor of oesophageal varices in patients with liver cirrhosis
  29. IL28B and IL10R −1087 polymorphisms are protective for chronic genotype 1 HCV infection and predictors of response to interferon-based therapy in an East-Central European cohort
  30. IL28B CC genotype: a protective factor and predictor of the response to interferon treatment in chronic hepatitis C virus infection
  31. Increased Baseline Proinflammatory Cytokine Production in Chronic Hepatitis C Patients with Rapid Virological Response to Peginterferon Plus Ribavirin
  32. Ganglioneuroma in the papilla of Vater with neurofibromatosis type 1: report of a case
  33. Upregulation and inhibition of the nuclear translocation of Oct4 during multistep gastric carcinogenesis
  34. Renal involvement in Crohn’s disease
  35. Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn’s disease. National data from Hungary
  36. Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease
  37. Autoimmune Pancreatitis in Hungary: A Multicenter Nationwide Study
  38. Serum fibrosis markers (Procollagen-III-peptide, hyaluronic acid, transforming growth factor β-1), aspartate-aminotransferase to platelet ratio index (APRI), and transient elastography (FibroScan) in patients with chronic HCV infection
  39. Cytokine (IL-10, IL-28B and LT-A) gene polymorphisms in chronic hepatitis C virus infection
  40. W1324 Medium Term Efficacy, Mucosal Healing and Safety of Adalimumab Therapy in Patients With Crohn's Disease. National Data From Hungary
  41. Effects of silymarin supplementation in patients with chronic hepatitis C receiving PEG-IFN + ribavirin antiviral therapy. A placebo-controlled double blind study
  42. Effects of silymarin supplementation in chronic hepatitis C patients treated with peg-interferon + ribavirin. A placebo-controlled double blind study
  43. Successful percutaneous drainage of a giant hydatid cyst in the liver
  44. Immunohistochemical distribution of vanilloid receptor, calcitonin-gene related peptide and substance P in gastrointestinal mucosa of patients with different gastrointestinal disorders
  45. Radiation-induced enterocolitis: basic and applied science
  46. Capsaicin prevents the indomethacin-induced gastric mucosal damage in human healthy subjects
  47. Mechanisms of action of retinoids in gastrointestinal mucosal protection in animals, human healthy subjects and patients
  48. Four response stages of capsaicin-sensitive primary afferent neurons to capsaicin and its analog: Gastric acid secretion, gastric mucosal damage and protection
  49. One year follow-up of patients after successful helicobacter pylori eradication therapy
  50. Prevalence of the factor V Leiden mutation in human inflammatory bowel disease with different activity
  51. The key-role of vagal nerve and adrenals in the cytoprotection and general gastric mucosal integrity
  52. Changes of serum carotenoids in patients with esophageal, gastric, hepatocellular, pancreatic and colorectal cancer
  53. Growth factors in ulcer healing: Lessons from recent studies
  54. Decrease of serum carotenoids in Crohn's disease
  55. 13C-Urea breath test is superior in sensitivity to detect Helicobacter pylori infection than either antral histology or rapid urease test
  56. Effects of indomethacin, with vitamin A or β-carotene, on the rat gastric mucosa: Extra-and intracellular membrane-bound ATP mechanisms
  57. Leiden mutation in patients with Crohn’s disease
  58. Decrease in serum levels of vitamin A and zeaxanthin in patients with colorectal polyp
  59. Cellular mechanisms of β-carotene-induced gastric cytoprotection in indomethacin-treated rats
  60. Statistical interpretation of the antisecretory effect of famotidine measured by intragastric pH-metry
  61. Dynamism of cytoprotective and antisecretory drugs in patients with unhealed gastric and duodenal ulcers
  62. Changes of gastric mucosal biochemistry in ethanol-treated rats with and without acute surgical vagotomy
  63. Vagal nerve and the gastric mucosal defense
  64. Correlations Between the Acute Chemical and Surgical Vagotomy-Induced Gastric Mucosal Biochemistry in Rats
  65. Mechanisms of Vagal Nerve in Gastric Mucosal Defense
  66. Failure of prostacyclin, β-carotene, atropine and cimetidine to produce gastric cyto- and general mucosal protection in surgically vagotomized rats
  67. A Biochemical and Pharmacological Approach to the Genesis of Ulcer Disease II.
  68. Angiogenesis and Growth Factors in Ulcer Healing